Objective: The purpose of the study was to investigate interleukin-6 (IL-6)
levels in the tear fluid and sera of patients with Sjogren syndrome (SS).
Participants: Twelve patients with primary SS and 12 normal control subject
s participated.
Intervention: Tear fluid and sera were obtained from the study and the cont
rol groups. Evaluation of tear fluid and sera IL-6 levels was done by using
a quantitative enzyme-linked immunosorbent assay kit. All assays were carr
ied out blindly with respect to diagnosis.
Main Outcome Measures: Tear fluid IL-6 levels were measured.
Results: The mean concentration (+/- standard error) of IL-6 in the tears o
f patients with SS was elevated significantly compared to that of normal co
ntrol subjects (88.6 +/- 16.2 vs, 42.1 +/- 10.6 pg/ml; P < 0.05), No signif
icant differences were noted in the serum IL-6 levels between the two group
s. A significant correlation (r = 0,742, P = 0.006) was found between tear
fluid IL-6 levels and the focus score of lip biopsy specimens in patients w
ith SS.
Conclusion: Tear fluid IL-6 levels may serve as an important marker for tea
r gland involvement in SS.